Results for: drugmaker+novartis+ag

Tokyo prosecutors raid Novartis Japan unit over clinical data probe

Novartis lung cancer drug gets key FDA designation

Novartis Q4 net profit rebounds to $2.1 billion

Novartis, Pfizer seek US approval of meningitis vaccines

India's rejection of drug patent could reverberate

Drug maker Novartis loses India patent battle

Novartis reshapes business with GSK, Lilly deals

India's top court to deliver Novartis judgment

Swiss mull creation of world's top minimum wage

Merck Q4 net drops 14 pct. on generic competition

Ahead of the Bell: Biogen shares keep climbing

Indian court to rule on generic drug industry

Investor pressure pushing drugmaker M&A deals

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Swiss vote on bosses' pay could hit offshore firms

Big Pharma pushes for U.S. action against India over patent worries

Swiss voters approve tough limits on bosses' pay

Valeant raises cash-stock offer for Allergan

Pfizer pulls plug on push to buy AstraZeneca

India rejects Bayer plea against cheap cancer drug

Pfizer 1Q profit up, but drugmaker cuts outlook

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in...

Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Drugmakers, Interpol ramp up fight against fakes

Novartis and Google to develop 'smart' contact lens

Drugmaker Novartis to eke out more cost savings to lift margins